BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26381082)

  • 1. MSH2 role in BRCA1-driven tumorigenesis: A preliminary study in yeast and in human tumors from BRCA1-VUS carriers.
    Maresca L; Spugnesi L; Lodovichi S; Cozzani C; Naccarato AG; Tancredi M; Collavoli A; Falaschi E; Rossetti E; Aretini P; Cervelli T; Galli A; Caligo MA
    Eur J Med Genet; 2015 Oct; 58(10):531-9. PubMed ID: 26381082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of BRCA1 missense variants on gene reversion in DNA double-strand break repair mutants and cell cycle-arrested cells of Saccharomyces cerevisiae.
    Lodovichi S; Bellè F; Cervelli T; Lorenzoni A; Maresca L; Cozzani C; Caligo MA; Galli A
    Mutagenesis; 2020 Mar; 35(2):189-195. PubMed ID: 31769492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MSH2/BRCA1 expression as a DNA-repair signature predicting survival in early-stage lung cancer patients from the IFCT-0002 Phase 3 Trial.
    Levallet G; Dubois F; Fouret P; Antoine M; Brosseau S; Bergot E; Beau-Faller M; Gounant V; Brambilla E; Debieuvre D; Molinier O; Galateau-Sallé F; Mazieres J; Quoix E; Pujol JL; Moro-Sibilot D; Langlais A; Morin F; Westeel V; Zalcman G
    Oncotarget; 2017 Jan; 8(3):4313-4329. PubMed ID: 28008145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A yeast recombination assay to characterize human BRCA1 missense variants of unknown pathological significance.
    Caligo MA; Bonatti F; Guidugli L; Aretini P; Galli A
    Hum Mutat; 2009 Jan; 30(1):123-33. PubMed ID: 18680205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of human Nter and Cter BRCA1 mutations using growth and localization assays in yeast.
    Millot GA; Berger A; Lejour V; Boulé JB; Bobo C; Cullin C; Lopes J; Stoppa-Lyonnet D; Nicolas A
    Hum Mutat; 2011 Dec; 32(12):1470-80. PubMed ID: 21922593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAD52 influences the effect of BRCA1/2 missense variants on homologous recombination and gene reversion in Saccharomyces cerevisiae.
    Lodovichi S; Bellè F; Mercatanti A; Spugnesi L; Cozzani C; Caligo MA; Cervelli T; Galli A
    FEMS Yeast Res; 2022 Jun; 22(1):. PubMed ID: 35472165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining Homologous Recombination and Phosphopeptide-binding Data to Predict the Impact of
    Petitalot A; Dardillac E; Jacquet E; Nhiri N; Guirouilh-Barbat J; Julien P; Bouazzaoui I; Bonte D; Feunteun J; Schnell JA; Lafitte P; Aude JC; Noguès C; Rouleau E; Lidereau R; Lopez BS; Zinn-Justin S; Caputo SM;
    Mol Cancer Res; 2019 Jan; 17(1):54-69. PubMed ID: 30257991
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterisation of gene expression profiles of yeast cells expressing BRCA1 missense variants.
    Di Cecco L; Melissari E; Mariotti V; Iofrida C; Galli A; Guidugli L; Lombardi G; Caligo MA; Iacopetti P; Pellegrini S
    Eur J Cancer; 2009 Aug; 45(12):2187-96. PubMed ID: 19493677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer in an MSH2 gene mutation carrier.
    Westenend PJ; Schütte R; Hoogmans MM; Wagner A; Dinjens WN
    Hum Pathol; 2005 Dec; 36(12):1322-6. PubMed ID: 16311127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cancer related BRCA1 missense variants decreases MMS-induced recombination in Saccharomyces cerevisiae without altering its nuclear localization.
    Lodovichi S; Vitello M; Cervelli T; Galli A
    Cell Cycle; 2016 Oct; 15(20):2723-31. PubMed ID: 27484786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenicity evaluation of BRCA1 and BRCA2 unclassified variants identified in Portuguese breast/ovarian cancer families.
    Santos C; Peixoto A; Rocha P; Pinto P; Bizarro S; Pinheiro M; Pinto C; Henrique R; Teixeira MR
    J Mol Diagn; 2014 May; 16(3):324-34. PubMed ID: 24607278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of BRCA1/2 defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes.
    Timms KM; Abkevich V; Hughes E; Neff C; Reid J; Morris B; Kalva S; Potter J; Tran TV; Chen J; Iliev D; Sangale Z; Tikishvili E; Perry M; Zharkikh A; Gutin A; Lanchbury JS
    Breast Cancer Res; 2014 Dec; 16(6):475. PubMed ID: 25475740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A high-throughput functional complementation assay for classification of BRCA1 missense variants.
    Bouwman P; van der Gulden H; van der Heijden I; Drost R; Klijn CN; Prasetyanti P; Pieterse M; Wientjens E; Seibler J; Hogervorst FB; Jonkers J
    Cancer Discov; 2013 Oct; 3(10):1142-55. PubMed ID: 23867111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel BRCA1 large genomic rearrangement in a Spanish breast/ovarian cancer family.
    Palanca Suela S; Esteban Cardeñosa E; Barragán González E; Oltra Soler S; de Juan Jiménez I; Chirivella González I; Segura Huerta A; Guillén Ponce C; Martínez de Dueñas E; Bolufer Gilabert P;
    Breast Cancer Res Treat; 2008 Nov; 112(1):63-7. PubMed ID: 18060491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation and Data-Integration of Yeast-Based Assays for Functional Classification of BRCA1 Missense Variants.
    Bellè F; Mercatanti A; Lodovichi S; Congregati C; Guglielmi C; Tancredi M; Caligo MA; Cervelli T; Galli A
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and epigenetic characterization of the BRCA1 gene in Brazilian women at-risk for hereditary breast cancer.
    Felicio PS; Melendez ME; Arantes LM; Kerr LM; Carraro DM; Grasel RS; Campacci N; Scapulatempo-Neto C; Fernandes GC; de Carvalho AC; Palmero EI
    Oncotarget; 2017 Jan; 8(2):2850-2862. PubMed ID: 27926510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional variant analyses (FVAs) predict pathogenicity in the BRCA1 DNA double-strand break repair pathway.
    Loke J; Pearlman A; Upadhyay K; Tesfa L; Shao Y; Ostrer H
    Hum Mol Genet; 2015 Jun; 24(11):3030-7. PubMed ID: 25652403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rapid and cell-free assay to test the activity of lynch syndrome-associated MSH2 and MSH6 missense variants.
    Drost M; Zonneveld JB; van Hees S; Rasmussen LJ; Hofstra RM; de Wind N
    Hum Mutat; 2012 Mar; 33(3):488-94. PubMed ID: 22102614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the expression of BRCA2 on spontaneous homologous recombination and DNA damage-induced nuclear foci in Saccharomyces cerevisiae.
    Spugnesi L; Balia C; Collavoli A; Falaschi E; Quercioli V; Caligo MA; Galli A
    Mutagenesis; 2013 Mar; 28(2):187-95. PubMed ID: 23328489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new alternative splice variant of BRCA1 containing an additional in-frame exon.
    Fortin J; Moisan AM; Dumont M; Leblanc G; Labrie Y; Durocher F; Bessette P; Bridge P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Pichette R; Plante M; Provencher L; Voyer P; Simard J
    Biochim Biophys Acta; 2005 Oct; 1731(1):57-65. PubMed ID: 16185777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.